NervGen Pharma's market cap is currently C$240.51M. The company's EPS TTM is C$-0.13; its P/E ratio is ―; NervGen Pharma is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is C$-0.05. See an overview of income statement, balance sheet, and cash flow financials.
